Hubbry Logo
Genetic disorderGenetic disorderMain
Open search
Genetic disorder
Community hub
Genetic disorder
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Genetic disorder
Genetic disorder
from Wikipedia

Genetic disorder
Diagram featuring examples of a disease located on each chromosome
SpecialtyMedical genetics

A genetic disorder is a health problem caused by one or more abnormalities in the genome. It can be caused by a mutation in a single gene (monogenic) or multiple genes (polygenic) or by a chromosome abnormality. Although polygenic disorders are the most common, the term is mostly used when discussing disorders with a single genetic cause, either in a gene or chromosome.[1][2] The mutation responsible can occur spontaneously before embryonic development (a de novo mutation), or it can be inherited from two parents who are carriers of a faulty gene (autosomal recessive inheritance) or from a parent with the disorder (autosomal dominant inheritance). When the genetic disorder is inherited from one or both parents, it is also classified as a hereditary disease. Some disorders are caused by a mutation on the X chromosome and have X-linked inheritance. Very few disorders are inherited on the Y chromosome or mitochondrial DNA (due to their size).[3]

There are well over 6,000 known genetic disorders,[4] and new genetic disorders are constantly being described in medical literature.[5] More than 600 genetic disorders are treatable.[6] Around 1 in 50 people are affected by a known single-gene disorder, while around 1 in 263 are affected by a chromosomal disorder.[7] Around 65% of people have some kind of health problem as a result of congenital genetic mutations.[7] Due to the significantly large number of genetic disorders, approximately 1 in 21 people are affected by a genetic disorder classified as "rare" (usually defined as affecting less than 1 in 2,000 people). Most genetic disorders are rare in themselves.[5][8]

Genetic disorders are present before birth, and some genetic disorders produce birth defects, but birth defects can also be developmental rather than hereditary. The opposite of a hereditary disease is an acquired disease. Most cancers, although they involve genetic mutations to a small proportion of cells in the body, are acquired diseases. Some cancer syndromes, however, such as BRCA mutations, are hereditary genetic disorders.[9]

Single-gene

[edit]
Prevalence of some single-gene disorders[10]
Disorder prevalence (approximate)
Autosomal dominant
Familial hypercholesterolemia 1 in 500[11]
Myotonic dystrophy type 1 1 in 2,100[12]
Neurofibromatosis type I 1 in 2,500[13]
Hereditary spherocytosis 1 in 5,000
Marfan syndrome 1 in 4,000[14]
Huntington's disease 1 in 15,000[15]
Autosomal recessive
Sickle cell anaemia 1 in 625[16]
Cystic fibrosis 1 in 2,000
Tay–Sachs disease 1 in 3,000
Phenylketonuria 1 in 12,000
Autosomal recessive polycystic kidney disease 1 in 20,000[17]
Mucopolysaccharidoses 1 in 25,000
Lysosomal acid lipase deficiency 1 in 40,000
Glycogen storage diseases 1 in 50,000
Galactosemia 1 in 57,000
X-linked
Duchenne muscular dystrophy 1 in 5,000
Hemophilia 1 in 10,000
Values are for liveborn infants

A single-gene disorder (or monogenic disorder) is the result of a single mutated gene. Single-gene disorders can be passed on to subsequent generations in several ways. Genomic imprinting and uniparental disomy, however, may affect inheritance patterns. The divisions between recessive and dominant types are not "hard and fast", although the divisions between autosomal and X-linked types are (since the latter types are distinguished purely based on the chromosomal location of the gene). For example, the common form of dwarfism, achondroplasia, is typically considered a dominant disorder, but children with two genes for achondroplasia have a severe and usually lethal skeletal disorder, one that achondroplasics(ones affected with achondroplasia) could be considered carriers for. Sickle cell anemia is also considered a recessive condition, but heterozygous carriers have increased resistance to malaria in early childhood, which could be described as a related dominant condition.[18] When a couple where one partner or both are affected or carriers of a single-gene disorder wish to have a child, they can do so through in vitro fertilization, which enables preimplantation genetic diagnosis to occur to check whether the embryo has the genetic disorder.[19]

Most congenital metabolic disorders known as inborn errors of metabolism result from single-gene defects. Many such single-gene defects can decrease the fitness of affected people and are therefore present in the population in lower frequencies compared to what would be expected based on simple probabilistic calculations.[20]

Autosomal dominant

[edit]

Only one mutated copy of the gene will be necessary for a person to be affected by an autosomal dominant disorder. Each affected person usually has one affected parent.[21]: 57  The chance a child will inherit the mutated gene is 50%. Autosomal dominant conditions sometimes have reduced penetrance, which means although only one mutated copy is needed, not all individuals who inherit that mutation go on to develop the disease. Examples of this type of disorder are Huntington's disease,[21]: 58  neurofibromatosis type 1, neurofibromatosis type 2, Marfan syndrome, hereditary nonpolyposis colorectal cancer, hereditary multiple exostoses (a highly penetrant autosomal dominant disorder), tuberous sclerosis, Von Willebrand disease, and acute intermittent porphyria. Birth defects are also called congenital anomalies.[22]

Autosomal recessive

[edit]

Two copies of the gene must be mutated for a person to be affected by an autosomal recessive disorder. An affected person usually has unaffected parents who each carry a single copy of the mutated gene and are referred to as genetic carriers. Each parent with a defective gene normally do not have symptoms.[23] Two unaffected people who each carry one copy of the mutated gene have a 25% risk with each pregnancy of having a child affected by the disorder. Examples of this type of disorder are albinism, medium-chain acyl-CoA dehydrogenase deficiency, cystic fibrosis, sickle cell disease, Tay–Sachs disease, Niemann–Pick disease, spinal muscular atrophy, and Roberts syndrome. Certain other phenotypes, such as wet versus dry earwax, are also determined in an autosomal recessive fashion.[24][25] Some autosomal recessive disorders are common because, in the past, carrying one of the faulty genes led to a slight protection against an infectious disease or toxin such as tuberculosis or malaria.[26] Such disorders include cystic fibrosis,[27] sickle cell disease,[28] phenylketonuria[29] and thalassaemia.[30]

X-linked dominant

[edit]
Schematic karyogram showing an overview of the human genome. It shows annotated bands and sub-bands as used in the nomenclature of genetic disorders. It shows 22 homologous chromosomes, both the female (XX) and male (XY) versions of the sex chromosome (bottom right), as well as the mitochondrial genome (to scale at bottom left).[citation needed]

X-linked dominant disorders are caused by mutations in genes on the X chromosome. Only a few disorders have this inheritance pattern, with a prime example being X-linked hypophosphatemic rickets. Males and females are both affected in these disorders, with males typically being more severely affected than females. Some X-linked dominant conditions, such as Rett syndrome, incontinentia pigmenti type 2, and Aicardi syndrome, are usually fatal in males either in utero or shortly after birth, and are therefore predominantly seen in females. Exceptions to this finding are extremely rare cases in which boys with Klinefelter syndrome (44+xxy) also inherit an X-linked dominant condition and exhibit symptoms more similar to those of a female in terms of disease severity. The chance of passing on an X-linked dominant disorder differs between men and women. The sons of a man with an X-linked dominant disorder will all be unaffected (since they receive their father's Y chromosome), but his daughters will all inherit the condition. A woman with an X-linked dominant disorder has a 50% chance of having an affected foetus with each pregnancy, although in cases such as incontinentia pigmenti, only female offspring are generally viable.

X-linked recessive

[edit]

X-linked recessive conditions are also caused by mutations in genes on the X chromosome. Males are much more frequently affected than females, because they only have the one X chromosome necessary for the condition to present. The chance of passing on the disorder differs between men and women. The sons of a man with an X-linked recessive disorder will not be affected (since they receive their father's Y chromosome), but his daughters will be carriers of one copy of the mutated gene. A woman who is a carrier of an X-linked recessive disorder (XRXr) has a 50% chance of having sons who are affected and a 50% chance of having daughters who are carriers of one copy of the mutated gene. X-linked recessive conditions include the serious diseases hemophilia A, Duchenne muscular dystrophy, and Lesch–Nyhan syndrome, as well as common and less serious conditions such as male pattern baldness and red–green color blindness. X-linked recessive conditions can sometimes manifest in females due to skewed X-inactivation or monosomy X (Turner syndrome).[citation needed]

Y-linked

[edit]

Y-linked disorders are caused by mutations on the Y chromosome. These conditions may only be transmitted from the heterogametic sex (e.g. male humans) to offspring of the same sex. More simply, this means that Y-linked disorders in humans can only be passed from men to their sons; females can never be affected because they do not possess Y-allosomes.[citation needed]

Y-linked disorders are exceedingly rare but the most well-known examples typically cause infertility. Reproduction in such conditions is only possible through the circumvention of infertility by medical intervention.

Mitochondrial

[edit]

This type of inheritance, also known as maternal inheritance, is the rarest and applies to the 13 genes encoded by mitochondrial DNA. Because only egg cells contribute mitochondria to the developing embryo, only mothers (who are affected) can pass on mitochondrial DNA conditions to their children. An example of this type of disorder is Leber's hereditary optic neuropathy.[31]

It is important to stress that the vast majority of mitochondrial diseases (particularly when symptoms develop in early life) are actually caused by a nuclear gene defect, as the mitochondria are mostly developed by non-mitochondrial DNA. These diseases most often follow autosomal recessive inheritance.[32]

Multifactorial disorder

[edit]

Genetic disorders may also be complex, multifactorial, or polygenic, meaning they are likely associated with the effects of multiple genes in combination with lifestyles and environmental factors. Multifactorial disorders include heart disease and diabetes. Although complex disorders often cluster in families, they do not have a clear-cut pattern of inheritance. This makes it difficult to determine a person's risk of inheriting or passing on these disorders. Complex disorders are also difficult to study and treat because the specific factors that cause most of these disorders have not yet been identified. Studies that aim to identify the cause of complex disorders can use several methodological approaches to determine genotypephenotype associations. One method, the genotype-first approach, starts by identifying genetic variants within patients and then determining the associated clinical manifestations. This is opposed to the more traditional phenotype-first approach, and may identify causal factors that have previously been obscured by clinical heterogeneity, penetrance, and expressivity.[citation needed]

On a pedigree, polygenic diseases do tend to "run in families", but the inheritance does not fit simple patterns as with Mendelian diseases. This does not mean that the genes cannot eventually be located and studied. There is also a strong environmental component to many of them (e.g., blood pressure).

Other such cases include:

Chromosomal disorder

[edit]
Chromosomes in Down syndrome, the most common human condition due to aneuploidy. There are three chromosomes 21 (in the last row).

A chromosomal disorder is a missing, extra, or irregular portion of chromosomal DNA.[33] It can be from an atypical number of chromosomes or a structural abnormality in one or more chromosomes. An example of these disorders is Trisomy 21 (the most common form of Down syndrome), in which there is an extra copy of chromosome 21 in all cells.[34]

Diagnosis

[edit]

Due to the wide range of genetic disorders that are known, diagnosis is widely varied and dependent of the disorder. Most genetic disorders are diagnosed pre-birth, at birth, or during early childhood however some, such as Huntington's disease, can escape detection until the patient begins exhibiting symptoms well into adulthood.[35]

The basic aspects of a genetic disorder rests on the inheritance of genetic material. With an in depth family history, it is possible to anticipate possible disorders in children which direct medical professionals to specific tests depending on the disorder and allow parents the chance to prepare for potential lifestyle changes, anticipate the possibility of stillbirth, or contemplate termination.[36] Prenatal diagnosis can detect the presence of characteristic abnormalities in fetal development through ultrasound, or detect the presence of characteristic substances via invasive procedures which involve inserting probes or needles into the uterus such as in amniocentesis.[37]

Prognosis

[edit]

Not all genetic disorders directly result in death; however, there are no known cures for genetic disorders. Many genetic disorders affect stages of development, such as Down syndrome, while others result in purely physical symptoms such as muscular dystrophy. Other disorders, such as Huntington's disease, show no signs until adulthood. During the active time of a genetic disorder, patients mostly rely on maintaining or slowing the degradation of quality of life and maintain patient autonomy. This includes physical therapy and pain management.

Treatment

[edit]
From personal genomics to gene therapy

The treatment of disorder an ongoing battle, with over 1,800 gene therapy clinical trials having been completed, are ongoing, or have been approved worldwide.[38][39] Despite this, most treatment options revolve around treating the symptoms of the disorders in an attempt to improve patient quality of life.

Gene therapy refers to a form of treatment where a healthy gene is introduced to a patient. This should alleviate the defect caused by a faulty gene or slow the progression of the disease. A major obstacle has been the delivery of genes to the appropriate cell, tissue, and organ affected by the disorder. Researchers have investigated how they can introduce a gene into the potentially trillions of cells that carry the defective copy. Finding an answer to this has been a roadblock between understanding the genetic disorder and correcting the genetic disorder.[40]

Epidemiology

[edit]

Around 1 in 50 people are affected by a known single-gene disorder, while around 1 in 263 are affected by a chromosomal disorder.[7] Around 65% of people have some kind of health problem as a result of congenital genetic mutations.[7] Due to the significantly large number of genetic disorders, approximately 1 in 21 people are affected by a genetic disorder classified as "rare" (usually defined as affecting less than 1 in 2,000 people). Most genetic disorders are rare in themselves.[5][8] There are well over 6,000 known genetic disorders,[4] and new genetic disorders are constantly being described in medical literature.[5]

History

[edit]

The earliest known genetic condition in a hominid was in the fossil species Paranthropus robustus, with over a third of individuals displaying amelogenesis imperfecta.[41]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
A genetic disorder is a health condition caused by changes, known as mutations or variants, in an individual's genes or chromosomes. These alterations disrupt normal biological functions, leading to a wide range of physical, developmental, or metabolic abnormalities that can manifest at birth or later in life. Genetic disorders are broadly classified into three categories: single-gene defects following Mendelian inheritance, chromosomal abnormalities such as aneuploidy, and multifactorial conditions involving multiple genes interacting with environmental factors. Inheritance patterns for single-gene disorders include autosomal dominant, where one mutated copy suffices to cause disease; autosomal recessive, requiring mutations in both copies; and X-linked variants, which disproportionately affect males due to hemizygosity. Chromosomal disorders, like trisomy 21 in Down syndrome, arise from errors in cell division leading to extra or missing genetic material. Notable examples encompass cystic fibrosis, an autosomal recessive disorder impairing chloride transport and causing lung and digestive issues; Huntington's disease, an autosomal dominant neurodegenerative condition; and sickle cell anemia, another recessive disorder altering hemoglobin structure. Over 6,000 rare genetic diseases have been identified, many monogenic, collectively affecting millions and underscoring the genome's causal role in disease etiology. While symptomatic treatments predominate, advances in genetic sequencing and targeted therapies, including gene editing, address root causes in select cases, though challenges persist in complex disorders.

Overview

Definition and Core Characteristics

A genetic disorder is a disease caused, wholly or in part, by an alteration in the DNA sequence deviating from the normal genomic configuration, resulting in disrupted gene expression or protein function critical to physiological processes. Such alterations encompass mutations, insertions, deletions, or duplications in genetic material, which can impair cellular mechanisms ranging from enzyme activity to structural integrity. These conditions affect approximately 1 in 200 live births for severe monogenic forms alone, with broader multifactorial genetic contributions underlying many common diseases. Core characteristics of genetic disorders include their origin in heritable or de novo genomic variants that alter protein-coding sequences or regulatory elements, often leading to loss-of-function, gain-of-function, or dominant-negative effects within cells. Unlike purely environmental diseases, they exhibit variable —where not all carriers manifest symptoms—and expressivity, with severity influenced by genetic background and modifiers, as seen in conditions like where CFTR gene mutations yield a spectrum from mild respiratory issues to fatal lung disease. Many arise from single variants or small indels in Mendelian fashion, while others involve larger chromosomal anomalies detectable via karyotyping, such as 21 in , which occurs in about 1 in 700 births due to errors. Fundamentally, genetic disorders persist due to incomplete purifying selection, with deleterious alleles maintained at low frequencies in populations; for instance, recessive disorders require biallelic for full manifestation, allowing carriers to evade fitness costs. hinges on identifying these causal variants through sequencing, revealing that over 7,000 Mendelian disorders have been cataloged, though polygenic risk scores increasingly explain like , where hundreds of loci contribute small effects. This underscores their mechanistic basis in causal DNA perturbations rather than or external triggers alone.

Distinction from Environmental and Infectious Diseases

Genetic disorders originate from alterations in an individual's genomic material, such as in DNA sequences, chromosomal aberrations, or copy number variations, which disrupt protein synthesis or cellular function and can be transmitted across generations via cells. In contrast, environmental diseases result from interactions with external agents—including chemical , , dietary imbalances, or physical stressors—that induce cellular damage or physiological imbalances without inherently modifying the DNA, though somatic mutations may occur secondarily. Infectious diseases, meanwhile, are triggered by the invasion and proliferation of exogenous pathogens like , viruses, fungi, or parasites, which cause through direct tissue invasion, release, or host immune overreaction, independent of primary host genetic defects. A primary differentiator is : genetic disorders exhibit predictable patterns (e.g., autosomal dominant or recessive), with risk quantifiable based on parental genotypes—for instance, 50% transmission probability in heterozygous autosomal dominant cases—allowing familial aggregation observable in pedigrees. Environmental diseases lack direct transmission, as their etiology ties to modifiable exposures; twin studies show low concordance in monozygotic pairs without shared environmental factors, emphasizing over fixed genetic liability. Infectious diseases similarly show minimal for acquisition, with susceptibility variations (e.g., 20-50% genetic contribution in some cases like HIV resistance via CCR5 delta32 ) modulating severity but not replacing exposure as the proximal cause; epidemiological data reveal outbreak patterns driven by contagion dynamics rather than . Onset and further demarcate these categories: genetic disorders often manifest congenitally or in early life with high in monogenic forms (e.g., >90% for by age 70), reflecting deterministic genotypic effects. Environmental diseases typically emerge post-exposure with variable latency (e.g., decades for asbestos-induced ), contingent on dose-response thresholds established in cohort studies like those of atomic bomb survivors. Infectious diseases present acutely or subacutely following , with resolution or chronicity hinging on clearance rather than intrinsic genetic fidelity, as evidenced by efficacy trials reducing incidence by 80-95% without altering host genomes. Diagnostic approaches underscore causal divergence: genetic disorders are confirmed via molecular techniques like next-generation sequencing or karyotyping, identifying causative variants with >99% specificity in targeted panels. Environmental etiologies rely on exposure histories, biomarkers (e.g., lead levels in blood), and exclusion of genetic confounders through epidemiological modeling. Infectious confirmation involves detection via , PCR, or , distinguishing them from sterile genetic pathologies. Treatment implications follow suit: genetic interventions target root mutations (e.g., CRISPR-based in clinical trials since 2018), while environmental focuses on avoidance and supportive care, and infectious therapy employs antimicrobials with clearance rates exceeding 90% for susceptible strains. This framework highlights how genetic disorders embody intrinsic, replicable molecular failures, whereas environmental and infectious counterparts reflect extrinsic perturbations amenable to interventions.

Etiology and Mechanisms

Types of Genetic Mutations and Variants

Genetic mutations are alterations in the DNA sequence that deviate from the , often disrupting function and contributing to disorders, whereas genetic variants broadly include any sequence differences, many of which are neutral polymorphisms. These changes can occur in cells, leading to heritable disorders, or somatically, affecting only specific tissues as in certain cancers. The most prevalent type involves single changes, but larger structural alterations also play significant roles in disease . Point mutations, or single nucleotide variants (SNVs), substitute one base for another and constitute the most common form of , with over 3.6 million identified in humans as of recent genomic surveys. Subtypes include synonymous variants, which do not alter the due to and typically have no functional impact; missense variants, which replace one with another and may impair protein function depending on the substitution's biochemical properties; and nonsense variants, which introduce premature stop codons, often resulting in truncated, nonfunctional proteins via . Frameshift mutations, though not point substitutions, arise from small insertions or deletions (indels) of not divisible by three, shifting the and frequently producing aberrant proteins; examples include those in caused by CFTR gene indels. Copy number variants (CNVs) involve duplications or deletions of DNA segments ranging from 1 kilobase to several megabases, altering and accounting for approximately 9% of pathogenic variants in rare genetic diseases according to analyses of over 13,000 cases. These dosage imbalances disrupt stoichiometric relationships in protein complexes, as seen in conditions like Charcot-Marie-Tooth disease type 1A from PMP22 duplication or from 22q11.2 deletion, where impairs developmental pathways. CNVs are detected via array or sequencing depth analysis, revealing their underappreciated prevalence in neurodevelopmental disorders. Structural variants encompass balanced rearrangements such as inversions, translocations, and insertions that do not necessarily change copy number but can juxtapose genes or regulatory elements, leading to aberrant expression; for instance, the BCR-ABL translocation in chronic myeloid leukemia fuses proto-oncogenes, though such events are more somatic, examples include balanced translocations predisposing to recurrent miscarriages or unbalanced offspring. Larger-scale variants, including aneuploidies like 21 in , represent extreme CNVs at the chromosomal level, arising from meiotic and affecting thousands of genes. Tandem repeat expansions, a specialized category, underlie in disorders like , where CAG trinucleotide repeats exceeding 36 units in HTT cause toxic polyglutamine aggregates. Variants are classified by clinical utility under frameworks like ACMG guidelines as pathogenic, likely pathogenic, variants of uncertain significance (VUS), likely benign, or benign, with pathogenicity determined by population frequency, computational predictions, and functional assays rather than sequence change alone. In genetic disorders, deleterious mutations often exhibit reduced or variable expressivity due to modifier loci or environmental factors, underscoring that sequence alteration alone does not dictate without empirical validation.

Inheritance Patterns and Modes

Genetic disorders arise from mutations in nuclear or and follow distinct patterns that determine the likelihood of transmission across generations. These patterns include autosomal dominant, autosomal recessive, X-linked, and , with rarer modes such as Y-linked. The mode depends on the involved and whether a single mutant suffices to cause disease, often influenced by effects or dominant-negative interactions. In autosomal dominant inheritance, the causative mutation lies on one of the 22 pairs of autosomes (non-sex chromosomes), and a single copy of the mutant produces the phenotype due to or a dominant-negative effect where the mutant protein interferes with the wild-type version. Affected individuals have a 50% chance of transmitting the mutation to each offspring, regardless of the child's sex, leading to across generations. Examples include , caused by CAG repeat expansions in the HTT gene, and , resulting from FBN1 mutations that disrupt structure. Autosomal recessive disorders require biallelic mutations (one from each parent) on autosomes to manifest, as a single wild-type typically provides sufficient functional protein, such as enzymes where 50% activity prevents symptoms—a phenomenon termed haplosufficiency. Carriers (heterozygotes) are asymptomatic, and affected individuals often emerge from consanguineous unions or populations with high carrier frequencies, with a 25% recurrence risk per pregnancy for carrier parents. Common examples are , due to CFTR gene defects impairing chloride transport, and sickle cell anemia from HBB mutations altering . X-linked inheritance involves genes on the . In X-linked recessive patterns, males (XY) express the disorder with one mutant , while females (XX) require two for full manifestation and often serve as carriers with variable expressivity due to . No male-to-male transmission occurs, as fathers pass Y to sons; affected males transmit to all daughters (carriers) but no sons. , from DMD gene deletions causing deficiency, exemplifies this, affecting approximately 1 in 3,500-5,000 male births. X-linked dominant disorders are rarer, affecting both sexes but often more severely in males due to hemizygosity; examples include from PHEX mutations disrupting regulation. Mitochondrial inheritance follows maternal lineage, as sperm contribute negligible mitochondria, and mutations in mtDNA (or nuclear genes affecting mitochondria) lead to variable heteroplasmy—where mutant mtDNA proportion determines severity. Disorders like , from mtDNA point mutations impairing , show incomplete and primarily affect males despite maternal transmission. , confined to the , are extremely rare and limited to male-specific conditions like certain spermatogenic failures, with direct father-to-son transmission.

Evolutionary Persistence of Deleterious Alleles

Deleterious alleles, which reduce organismal fitness when expressed, persist in human populations primarily through mutation-selection balance, wherein recurrent mutations introduce harmful variants at a rate offset by purifying selection removing them. The experiences approximately 100-200 new mutations per individual per generation, most of which are neutral or weakly deleterious, leading to an equilibrium frequency for recessive deleterious alleles approximated by qμ/sq \approx \sqrt{\mu / s}
Add your contribution
Related Hubs
User Avatar
No comments yet.